Ultragenyx Pharmaceutical Market Cap

Ultragenyx Pharmaceutical has a market cap or net worth of 3.22 billion as of January 23, 2025. Its market cap has increased by 5.66% in one year.

Market Cap

3.22B

Enterprise Value

3.31B

Revenue

390.02M

Ranking

n/a

PE Ratio

n/a

Stock Price

41.84

Market Cap Chart

Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from 746.36M to 3.22B, an increase of 331.05%. That is a compound annual growth rate of 14.23%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	3.09B	-0.29%
Dec 31, 2024	3.10B	0.60%
Dec 29, 2023	3.08B	14.35%
Dec 30, 2022	2.70B	-36.32%
Dec 31, 2021	4.23B	-36.89%
Dec 31, 2020	6.71B	260.04%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shell	168.73B
AstraZeneca	167.37B
HSBC Holdings	145.28B
Unilever	113.90B
Rio Tinto Group	86.42B
RELX PLC	73.51B
BP p.l.c.	68.49B
British American Tobacco p.l.c.	65.16B

Market Cap Rankings